fraxinellone has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Hou, L; Huang, L; Liu, Q; Liu, Y; Shen, L; Zhang, X | 1 |
1 other study(ies) available for fraxinellone and Malignant Melanoma
| Article | Year |
|---|---|
Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma.
Topics: Animals; Benzofurans; Cancer Vaccines; Cancer-Associated Fibroblasts; Cell Line, Tumor; Disease Models, Animal; Emulsions; Immunologic Factors; Melanoma; Mice; Nanoparticles; Treatment Outcome; Tumor Microenvironment | 2018 |